Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationMultiple MyelomaPeripheral Blood Stem Cell TransplantationTransplantation ConditioningMelphalanAntineoplastic Combined Chemotherapy ProtocolsBone MarrowCombined Modality TherapyTreatment OutcomeBone Marrow CellsRemission InductionSalvage TherapyStem CellsDisease-Free SurvivalCyclophosphamideLymphoma, Non-HodgkinHematopoietic Stem Cell MobilizationEtoposideBone Marrow PurgingHodgkin DiseaseRecurrenceGraft vs Host DiseaseCarmustineHematopoietic Stem CellsCytarabineMyeloablative AgonistsLiver TransplantationSurvival RateWhole-Body IrradiationGraft SurvivalSurvival AnalysisHematologic NeoplasmsVincristineAntigens, CD34Retrospective StudiesBusulfanThiotepaPrognosisGranulocyte Colony-Stimulating FactorDoxorubicinFollow-Up StudiesTime FactorsKidney TransplantationDexamethasoneLymphoma, Mantle-CellLeukapheresisAmyloidosisCell TransplantationAntineoplastic Agents, AlkylatingBone and BonesAntibodies, Monoclonal, Murine-DerivedThalidomideBoronic AcidsTransplantation ChimeraPyrazinesAntineoplastic AgentsLymphomaMesenchymal Stem Cell TransplantationTissue DonorsLymphoma, FollicularPrednisoneLymphoma, T-Cell, PeripheralNeoplasm, ResidualLeukemia, Myeloid, AcuteAutograftsIfosfamideHematopoiesisMyelodysplastic SyndromesCord Blood Stem Cell TransplantationHeart TransplantationImmunosuppressive AgentsCell DifferentiationInduction ChemotherapyPodophyllotoxinLung TransplantationLeukemiaIdarubicinLymphoma, Large B-Cell, DiffuseBlood Component RemovalCells, CulturedAntibodies, MonoclonalProspective StudiesHistocompatibility TestingMaintenance ChemotherapyFeasibility StudiesTransplantation ImmunologyGraft RejectionLymphoma, B-CellNeoplasm Recurrence, LocalFlow CytometryLeukemia, MyeloidOrgan TransplantationBone Marrow DiseasesT-LymphocytesHistocompatibilityEmbryonic Stem Cells